BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Ivashkin VT, Lapina TL, Bondarenko OY, Sklanskaya OA, Grigoriev PY, Vasiliev YV, Yakovenko EP, Gulyaev PV, Fedchenko VI. Azithromycin in a triple therapy for H.pylori eradication in active duodenal ulcer. World J Gastroenterol 2002; 8(5): 879-882 [PMID: 12378634 DOI: 10.3748/wjg.v8.i5.879]
URL: https://www.wjgnet.com/1007-9327/full/v8/i5/879.htm
Number Citing Articles
1
Ignasi Puig, Mireia Baylina, Jordi Sánchez-Delgado, Sheila López-Gongora, David Suarez, Pilar García-Iglesias, Neus Muñoz, Javier P. Gisbert, Cristina Dacoll, Henry Cohen, Xavier Calvet. Systematic review and meta-analysis: triple therapy combining a proton-pump inhibitor, amoxicillin and metronidazole forHelicobacter pylorifirst-line treatmentJournal of Antimicrobial Chemotherapy 2016; 71(10): 2740 doi: 10.1093/jac/dkw220
2
Jie Dong, Xiao-Feng Yu, Jian Zou. Azithromycin-containing <italic>versus</italic> standard triple therapy for <italic>Helicobacter pylori</italic> eradication: A meta-analysisWorld Journal of Gastroenterology 2009; 15(48): 6102-6110 doi: 10.3748/wjg.15.6102
3
Yang Bai, Ying-Chun Dai, Jian-Dong Li, Jun Nie, Qing Chen, Hong Wang, Yong-Yu Rui, Ya-Li Zhang, Shou-Yi Yu. Acute diarrhea during army field exercise in southern ChinaWorld Journal of Gastroenterology 2004; 10(1): 127-131 doi: 10.3748/wjg.v10.i1.127
4
M. Escobedo-Belloc, F. Bosques-Padilla. The rise of antibiotic resistance to Helicobacter pylori in Mexico: Is azithromycin plus levofloxacin the answer?Revista de Gastroenterología de México (English Edition) 2019; 84(3): 271 doi: 10.1016/j.rgmxen.2018.10.006
5
Laura Cidrão Frota, Maria do Perpétuo Socorro Saldanha da Cunha, Carlos René Lima Luz, Antonio Haroldo de Araujo-Filho, Luciano A. S. Frota, Lucia Libanez Bessa Campelo Braga. Helicobacter pylori eradication using tetracycline and furazolidone versus amoxicillin and azithromycin in lansoprazole based triple therapy: an open randomized clinical trialArquivos de Gastroenterologia 2005; 42(2): 111 doi: 10.1590/S0004-28032005000200009
6
Naoki Chiba. Evidence‐Based Gastroenterology and Hepatology2010; : 102 doi: 10.1002/9781444314403.ch6
7
Asma Nizam, Zao Iman Chaudary, Saad Ali Ahmad, Nimra Nawaz, Zainab Riaz, Aamir Shehzad, Muhammad Irfan Jamil. Comparison of the Efficacy of Two-Week Vonoprazan Versus Lansoprazole-Based Quadruple Sequential Antibiotic Therapy in Eradicating Helicobacter pylori Infection: A Non-randomized Clinical TrialCureus 2024;  doi: 10.7759/cureus.52758
8
Naoki Chiba. Evidence‐based Gastroenterology and Hepatology2004; : 83 doi: 10.1002/9780470987025.ch5
9
Jae Yeon Kim, Nayoung Kim, Sung Jung Kim, Gwang Ho Baik, Gwang Ha Kim, Jung Mogg Kim, Ryoung Hee Nam, Hong Bin Kim, Dong Ho Lee, Hyun Chae Jung, In Sung Song. Regional Difference of Antibiotic Resistance ofHelicobacter pyloriStrains in KoreaThe Korean Journal of Gastroenterology 2011; 57(4): 221 doi: 10.4166/kjg.2011.57.4.221
10
Jung Mogg Kim, Joo Sung Kim, Nayoung Kim, Sang Gyun Kim, Hyun Chae Jung, In Sung Song. Comparison of primary and secondary antimicrobial minimum inhibitory concentrations for Helicobacter pylori isolated from Korean patientsInternational Journal of Antimicrobial Agents 2006; 28(1): 6 doi: 10.1016/j.ijantimicag.2006.02.015
11
Shahram Agah, Babak Shazad, Babak Abbaszadeh. Comparison of azithromycin and metronidazole in a quadruple-therapy regimen for Helicobacter pylori eradication in dyspepsiaSaudi Journal of Gastroenterology 2009; 15(4): 225 doi: 10.4103/1319-3767.56091
12
Jae Yeon Kim, Nayoung Kim, Hyun Kyung Park, Hyun Jin Jo, Cheol Min Shin, Sang Hyub Lee, Young Soo Park, Jin-Hyeok Hwang, Jin-Wook Kim, Sook-Hyang Jeong, Dong Ho Lee, Ryoung Hee Nam, Jung Mogg Kim, Ji Hyun Lee, Hyun Chae Jung, In Sung Song. Primary Antibiotic Resistance ofHelicobacter pyloriStrains and Eradication Rate according to Gastroduodenal Disease in KoreaThe Korean Journal of Gastroenterology 2011; 58(2): 74 doi: 10.4166/kjg.2011.58.2.74
13
Jung Mogg Kim, Joo Sung Kim, Hyun Chae Jung, Nayoung Kim, Young-Jeon Kim, In Sung Song. Distribution of Antibiotic MICs for Helicobacter pylori Strains over a 16-Year Period in Patients from Seoul, South Korea Antimicrobial Agents and Chemotherapy 2004; 48(12): 4843 doi: 10.1128/AAC.48.12.4843-4847.2004
14
Shahrokh Mousavi, Jafar Toussy, Siamak Yaghmaie, Mehrdad Zahmatkesh. Azithromycin in one week quadruple therapy for <italic>H pylori</italic> eradication in IranWorld Journal of Gastroenterology 2006; 12(28): 4553-4556 doi: 10.3748/wjg.v12.i28.4553
15
Chuan-Yong Guo, Yun-Bin Wu, Heng-Lu Liu, Jian-Ye Wu, Min-Zhang Zhong. Clinical evaluation of four one-week triple therapy regimens in eradicating <i>Helicobacter pylori</i> infectionWorld Journal of Gastroenterology 2004; 10(5): 747-749 doi: 10.3748/wjg.v10.i5.747
16
M. Escobedo-Belloc, F. Bosques-Padilla. El incremento en la resistencia de Helicobacter pylori a los antibióticos en México: ¿son la azitromicina más levofloxacina la respuesta?Revista de Gastroenterología de México 2019; 84(3): 271 doi: 10.1016/j.rgmx.2018.10.005